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Objectives: To undertake a prospective clinical study to evaluate the
clinical performance of the RoxolidTM bone level, narrow platform implant
in the restoration of missing teeth in the anterior maxilla of patients with
mild hypodontia.
Method: Sixteen patients (9 female, 7 male: age range 18-27 years) with
congenital absence of teeth in the anterior maxilla who met inclusion
criteria were invited to participate in the study. All of the patients were
recruited at Cork Dental School and Hospital, Ireland. Prior to treatment,
details of dental status, plaque and bleeding scores were recorded.
Patients also completed an oral health related quality of life measure
(OHIP-20), and satisfaction with appearance was measured using a visual
analogue scale (VAS). Upon completion of orthodontic treatment and
detailed restorative treatment planning, implants were placed using a
standardized two stage surgical protocol. Surgical stents modelled on a
diagnostic wax-up were used in all cases. Implant stability was recorded
at the time of implant placement (T0) using a resonance frequency
analyser (Ostell™) and measured using implant stability quotients (ISQ).
Standardised periapical radiographs were recorded using customized
Rinn holders at each data collection point. These measurements were
repeated at abutment connection (T1) and at the time of placement of the
final restoration (T2). At the 12 month post treatment follow –up review
(T3), patients had a full dental and periodontal examination and
completed an OHIP-20 questionnaire and a VAS (Figure 2). The
outcomes of interest in the study were implant survival, radiographic bone
changes and the impact of treatment on quality of life.
Figure 2: Study profile
Background: Congenital absence of teeth, commonly known as hypodontia,
has a reported prevalence of between 2 and 6%. It presents many clinical
challenges, and it has a significant impact on psycho-social well being of
patients. A typical presentation of mild hypodontia is shown in Figure 1.
Rehabilitation of these patients with implants is complicated by small bone
volume, and it requires multi-disciplinary input. Potential sites for implants in
the anterior maxilla are compromised by low bone volume. A novel narrow
implant made with TiZr alloy, RoxolidTM (Straumann AG), has been developed
which offers the potential to place implants in these patients with minimal or
no requirement for bone augmentation surgery.
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Conclusions: It was possible to place narrow platform Roxolid TM implants
in all of the patients with minimal or no ridge augmentation. Good implant
stability values were achieved. There has been minimal bone loss after 12
months. Patients reported a high level of satisfaction with the cosmetic
outcome of treatment, and oral health related quality of life improved
following treatment.
This study was supported by Institut Straumann AG, (study 
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Results: Of the 16 patients currently enrolled in the study, 12 have so far
completed one year of follow up. 18 RoxolidTM bone level SLActive, 3.3mm
diameter implants were placed in these patients. The implants used were
10mm and 12mm in length. All surgical procedures proceeded
uneventfully, although alveolar ridge augmentation was required at four
surgical sites (Figure 3).
Mean implant stability values measured using resonance frequency
analysis increased from 69.6 at surgical placement to 73.8 at time of
placement of the restoration. Bone loss around the implants was minimal
during the first year of function, and a typical profile is shown in Figure 4 .
Figure 1: Patient with congenital absence of maxillary  lateral incisors
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Figure 3: Surgical placement left lateral incisor region
Patient satisfaction with the cosmetic outcomes from treatment was very
high, with satisfaction scores at one year ranging from 85/100 to 98/100.
In terms of oral health related quality of life, there was a significant
improvement in pre-post treatment OHIP -20 scores (P<0.05, paired t-test).
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Figure 4: Radiographic images of implant at V4 and V6
